Docking the Proteome for New Ligands and Functional Associations
Docking the Proteome for New Ligands and Functional Associations
批准号:
8911649
负责人:
Trent E Balius
金额:
$2.97万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-01-01 至 2015-12-31
关键词:
ADRB2 geneAdenBiochemistryCHES1 geneCharacteristicsChemicalsChemistryCollaborationsCommunitiesComputing MethodologiesDatabasesDevelopmentDockingDrug TargetingDrug toxicityEpidermal Growth Factor ReceptorG Protein-Coupled Receptor GenesGeometryGoalsHandHistamineLigandsLinkMAP Kinase GeneMAPK14 geneMechanicsMethodsMetricModelingMolecularNatureOne-Step dentin bonding systemPharmaceutical PreparationsPharmacologyProteinsProteomeRetrospective StudiesRoentgen RaysStructureTechniquesTestingTimeacrosinbasedrug mechanisminterestpublic health relevancesmall moleculestructural biologytool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Two overarching goals in chemical and structural biology are finding ligands for every protein (Schreiber, S. L., Nat Chem Biol 2005), and identifying the functions and associations among proteins based on their structure. For the last decade, these goals have been pursued empirically (Gerlt, J. A.; et al., Biochemistry 2011). I will
argue that there is a need for computation in both ligand discovery and functional association of proteins. I will also argue that such goals, correctly framed, are now becoming obtainable for computational methods, and that at scale they are essentially only pragmatic computationally. In the last five years, structure-based docking screens have seen two important advances. First, the technique has predicted new chemotypes for over 60 targets. Whereas docking retains key liabilities, and cannot rank order ligands, it can now, with some reliability, prioritize likely molecules as candidates. Second, the technique has become fast. I will show that the method can screen the structurally accessible and interesting proteome-about 4000 targets-in four months. A second development is the advent of chemoinformatics techniques to compare targets by ligand similarity, rather than the structural or sequence similarity. It turns out that ligand similarity reveals associations that are curiously opaque to sequence and structure, and this has been used to make surprising and high-profile predictions of drug off-targets (Keiser, M. J.; et al., Relating protein pharmacology by ligand chemistry, Nat Biotech 2007,25(2), 197-206), drug mechanism of action (Gregori-Puigjane, E.; et al., Proc Natl Acad Sci U S A 2012; Keiser, M. J.; et al., Nature 2009), and drug toxicities (Lounkine, E.; et al., Nature 2012). Very recently the technique has been expanded to reorganize the GPCR dendogram (Lin, H.; et al., Nature Methods 2013, accepted), and I will take that tack to a whole proteome level by relating docking hit lists to associate proteins. The docking hit lists and the associations among them will enable three questions: "What compounds are available that might modulate my target", "what other targets might my target be associated with?" and, when appropriate, "what is the function of my target?" All results will be made accessible online.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Docking the Proteome for New Ligands and Functional Associations
-
批准号:8592226
-
项目类别:
-
资助金额:$2.18万
-
财政年份:2014
-
负责人:Trent E Balius
-
依托单位:
Docking the Proteome for New Ligands and Functional Associations
-
批准号:8792154
-
项目类别:
-
资助金额:$5.42万
-
财政年份:2014
-
负责人:Trent E Balius
-
依托单位:
Characterizing the Mechanism of Cancer-Causing and Resistance Mutation of EGFR
-
批准号:7626665
-
项目类别:
-
资助金额:$2.99万
-
财政年份:2008
-
负责人:Trent E Balius
-
依托单位:
Characterizing the Mechanism of Cancer-Causing and Resistance Mutation of EGFR
-
批准号:7488156
-
项目类别:
-
资助金额:$2.86万
-
财政年份:2008
-
负责人:Trent E Balius
-
依托单位:
Characterizing the Mechanism of Cancer-Causing and Resistance Mutation of EGFR
-
批准号:8066701
-
项目类别:
-
资助金额:$3.15万
-
财政年份:2008
-
负责人:Trent E Balius
-
依托单位:
国内基金
海外基金
sRNA18-AdeN-AdeIJK通路介导鲍曼不动杆菌对碳青霉烯类抗生素耐药的作用机制研究
-
批准号:81702043
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:韩蕾
-
依托单位: